Inventor
BATCHELOR MARK JAMES
GB15 patents
⚠️ This page may combine multiple inventors who share the name “BATCHELOR MARK JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
6 patentsUS5874424AFeb 23, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA141 citations98
US6423840B1Jul 23, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA40 citations96
US6258948B1Jul 10, 2001
Inhibitors of Interleukin-1β converting enzyme
VERTEX PHARMA42 citations96
US6204261B1Mar 20, 2001
Inhibitors of interleukin-1β Converting enzyme inhibitors
VERTEX PHARMA80 citations96
US7790713B2Sep 7, 2010
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA24 citations92
US6008217ADec 28, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA37 citations92
CELLTECH THERAPEUTICS LTD
4 patentsUS6093716AJul 25, 2000
Substituted 2-pyrimidineamines and processes for their preparation
CELLTECH THERAPEUTICS LTD267 citations99
US6114333ASep 5, 2000
2-Pyrimidineamine derivatives and processes for their preparation
CELLTECH THERAPEUTICS LTD103 citations96
US6057329AMay 2, 2000
Fused polycyclic 2-aminopyrimidine derivatives
CELLTECH THERAPEUTICS LTD63 citations96
US6133257AOct 17, 2000
Fused polycyclic 2-aminopyrimidine derivatives
CELLTECH THERAPEUTICS LTD23 citations92
CELLTECH R&D LTD
3 patentsUS6579983B1Jun 17, 2003
5-cyano-2-aminopyrimidine derivatives
CELLTECH R&D LTD228 citations98
US6552029B1Apr 22, 2003
2-pyrimidineamine derivatives and processes for their preparation
CELLTECH R&D LTD58 citations95
US6599908B1Jul 29, 2003
Fused polycyclic 2-aminopyrimidine derivatives
CELLTECH R&D LTD47 citations92